News – Page 546 – Endpoints News

Federal jury convicts Kansas chem professor on four counts in 'China Initiative' case

4 years ago

Harpoon's fall continues as CMO departs weeks after lead program axed

4 years ago

After taking a $73M hit, J&J partner Genmab loses arbitration over royalties on megablockbuster Darzalex

4 years ago

Enamine will resume operations on limited basis, CEO says, as Russian forces withdraw from Ukrainian capital

4 years ago

Xenotransplant gene editor eGenesis snags transplant expert as CMO; John Tsai, Susanne Schaffert among the hard cuts ...

4 years ago

CMS finalizes restrictions on Biogen's Alzheimer's drug coverage, will only fund use in clinical trials

4 years ago

When high costs mean unfilled prescriptions: New study digs into Medicare data on seniors skipping out

4 years ago

House, Senate Dems introduce legislation to combat 'abusive' pharma business practices

4 years ago

Alnylam's Yvonne Greenstreet sees a massive pay raise as John Maraganore passes the torch

4 years ago

AI companies join forces to boost data use in manufacturing; Construction complete at 2 sites for added API capacity

4 years ago

Merck opens Virginia plant to support UNICEF deal for HPV vaccines

4 years ago

Q&A: How Penn's CAR-T manufacturing discovery has drastically reduced timelines

4 years ago

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

4 years ago

Law groups, professors lash out against Thermo Fisher in suit over the 'immortal cells' of Henrietta Lacks

4 years ago

Asthma patients are unfamiliar with biologic brands, but open to try — Phreesia survey

4 years ago

Neuro player Jazz Pharmaceuticals dives into immuno-oncology, inking cytokine pact with Werewolf

4 years ago

RA, Atlas-backed biotech spins up with $110M in pursuit of protein degradation via molecular glues

4 years ago

Final coverage decision for some Alzheimer's drugs is almost here: What to remember and what to expect

4 years ago

In a one-two gut punch after kidney drug CRL, Akebia slapped with partial hold and will lay off 42% of staff

4 years ago

Flagship's Noubar Afeyan recruits the next CEO for one of its stealth biotech startups

4 years ago

After imploding three years ago, Aptinyx follows a painful setback with yet another PhII failure

4 years ago

Quality metrics for pharma manufacturing is back in a big way, with FDA pledging to 'objectively rate' firms

4 years ago

With an eye to 'non-obvious binding sites,' CBC Group launches precision medicine play with $67M and ex-Editas exec ...

4 years ago

Two biotechs press forward with IPOs in a bid to stir market from hibernation

4 years ago

First page Previous page 543 544 545546547 548 549 Next page Last page